Roche, Biogen suspends arthritis drug after deaths | Reuters
Links shared publicly online about this topic.
- 1,329total visits
Roche, Biogen suspends arthritis drug after deaths | Reuters
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its
View full resource at reuters.com
Tags: Arthritis, Arthritis Medication, Rheumatoid Arthritis, Lupus, Drug, Biogen Idec
Most Recently Shared on March 8, 2010 at 6:23 pm By:
Roche, Biogen suspends arthritis drug after deaths: ZURICH (Reuters) - Swiss drugmaker Roche Holding AG and U.S. b... http://bit.ly/aJ5EKZ
Roche, Biogen suspends arthritis drug after deaths | Reuters
reuters.com — “ZURICH (Reuters) - Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its” View full resource at reuters.com
Most Recently Shared on March 8, 2010 at 6:23 pm By:
Roche, Biogen suspends arthritis drug after deaths: ZURICH (Reuters) - Swiss drugmaker Roche Holding ... http://bit.ly/aYfYId #health #news
Advertisement
